Where is Oxford Immunotec headquartered?

Oxford Immunotec is located in Abingdon, england.

Who invested in Oxford Immunotec?

Oxford Immunotec has 13 investors including Geekdom Fund And Geekdom Fund.

How much funding has Oxford Immunotec raised to date?

Oxford Immunotec has raised ____.

When was the last funding round for Oxford Immunotec?

Oxford Immunotec closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

oxfordimmunotec.com

Oxford Immunotec

Oxford Immunotec is a diagnostics company that develops and commercializes T cell-based immunotherapies for the treatment of infectious diseases.

Business Model:

Revenue: $57.3M

Employees: 201-500

Oxford Immunotec was acquired by PerkinElmer.
The acquisition happend on 2021-01-07.
Details of the transaction were not public

Acquirer

PerkinElmer

General Information

Geographic Data

Address: 143 Park Drive

City: Abingdon

State: england

Zip: OX14 4SE

Country: GB

Financial Info

Stage:

post ipo debt

Raised Last:

$40M

Raised Total:

$147M

Social

Facebook

Twitter

Crunchbase

Metrics

3,956,022Website Global Rank

3,136Website Monthly Traffic

Twitter Followers

Description

Oxford Immunotec is a diagnostics company that develops and commercializes T cell-based immunotherapies for the treatment of infectious diseases.

Contact Phone:

Contact Email:

IPO Details

Oxford Immunotec went public on 11/22/2013 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
11/22/2013

Ticker Symbol:
OXFD

IPO Price:
$12/share

Amount Raised:
$64M

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
1/2015	Post-IPO Equity		$53.7M
5/2010	Series D	7	$26M	Spark Ventures Wellington Partners University of Oxford New Leaf Venture Partners Molten Ventures Kaiser Permanente Ventures Clarus Ventures Spark Ventures
11/2003	Series A	1	$4.2M	Quester Capital Quester Capital
6/2012	Equity	8	$28M	Invesco Wellington Partners Clarus Ventures Molten Ventures Spark Ventures New Leaf Venture Partners Kaiser Permanente Ventures Imperial Innovations Imperial Innovations Invesco Invesco Wellington Partners Clarus Ventures Molten Ventures Spark Ventures New Leaf Venture Partners Kaiser Permanente Ventures Imperial Innovations Imperial Innovations Invesco
8/2005	Series B		$12.6M	Prelude Trust Quester Capital The Dow Company
8/2005	Series B	3	$12.6M	Prelude Trust The Dow Chemical Company Quester Capital Prelude Trust The Dow Chemical Company Quester Capital
10/2007	Series C		$0	Clarus Ventures Wellington Partners NTEC Prelude Trust Quester Capital The Dow Chemical Company Clarus Ventures Wellington Partners NTEC Prelude Trust Quester Capital The Dow Chemical Company
10/2016	Post-IPO Debt	1	$40M	MidCap Financial MidCap Financial MidCap Financial MidCap Financial
10/2007	Series C	6	$40M	Clarus Ventures Wellington Partners NTEC Prelude Trust Quester Capital The Dow Company Clarus Ventures Wellington Partners
8/2005	Series B	3	$12.6M	Prelude Trust Prelude Trust
11/2003	Series A	1	$4.2M	Quester Capital Quester Capital

Acquisitions

Announced Date	Name	Price
10/2016	Immunetics
6/2016	IMUGEN, Inc.
8/2014	Boulder Diagnostics

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details